(Q33752501)

29 July 2017

1 reference

title

Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders (English)

1 reference

29 July 2017

0 references

Nutt DJ

1

1 reference

29 July 2017

Forshall S

2

1 reference

29 July 2017

Bell C

3

1 reference

29 July 2017

Rich A

4

1 reference

29 July 2017

Sandford J

5

1 reference

29 July 2017

Nash J

6

1 reference

29 July 2017

Argyropoulos S

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

European Neuropsychopharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

9 Suppl 3

1 reference

29 July 2017

page(s)

S81-6

1 reference

Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

5-HT1A receptor-effector system responsivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Fatal overdose with citalopram.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Preliminary studies of the kinetics of citalopram in man

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

1 reference

7 January 2021

A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Paroxetine efficacy in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Tryptophan depletion in obsessive-compulsive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Relapse of depression after rapid depletion of tryptophan.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

Multiple serotonin receptors: too many, not enough, or just the right number?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900030-9

7 January 2021

10.1016/S0924-977X(99)00030-9

Identifiers

DOI

1 reference

29 July 2017

1 reference